Skip to content

Comparative Dexamedetomidine as an adjunct to Walant solution for distal radius fracture via Walant technique

Comparative Dexamedetomidine as an adjunct to Walant solution for distal radius fracture via Walant technique

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250722066589N3
Enrollment
40
Registered
2025-08-03
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparing the effects of adding dexmedetomidine to WALANT solution on onset, block duration, pain levels during and after surgery, and bleeding rate in distal radius fracture patients..

Interventions

Intervention 1: Intervention group: Received Valant solution plus dexmedetomidine (20 ml 2% lidocaine, 2 CC 1000/01 epinephrine, 14 CC normal saline, 4 CC 8.4% sodium bicarbonate [total 40 CC], and 50

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with distal radius fractures who are candidates for surgery

Exclusion criteria

Exclusion criteria: surgical site infection Peripheral vascular disease Severe anxiety lack of cooperation Needle phobia Coagulation disorders Ages under 18 or over 80 open fracture Fracture duration exceeding three weeks patient unwillingness to participate

Design outcomes

Primary

MeasureTime frame
Time of onset of anesthesia. Timepoint: Prior to intervention. Method of measurement: hour.;Pain levels. Timepoint: Baseline (V1), 10 minutes post-injection (V2), incision (V3), gentle manipulation (V4), vigorous manipulation (V5), first drilling (V6), and postoperatively. Method of measurement: Visual Analog Scale score.;Sedation level. Timepoint: During surgery, during recovery, and 4 and 24 hours after surgery. Method of measurement: Richmond Agitation Sedation Scale.;Hand movement disability. Timepoint: 2 weeks, 1 month, 2 months, 3 months and 6 months after surgery. Method of measurement: QUICK DASH Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Abniki

Shahid Beheshti University of Medical Sciences

dr.abniki@sbmu.ac.ir+98 21 25719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026